Afrezza Dosing Basics: Cartridge Units and Administration
Afrezza inhaled insulin cartridges are available in three fixed-dose strengths: 4 units (blue), 8 units (green), and 12 units (purple), with each cartridge containing a single dose that is fully consumed upon inhalation. 1
Cartridge Specifications
- Each cartridge delivers one complete dose - there are no partial doses or multiple uses per cartridge 2, 3, 4
- Three available strengths:
Dose Combinations for Higher Requirements
- For doses exceeding 12 units, multiple cartridges must be used in combination 3, 4
- Example combinations:
- 16 units = one 12-unit + one 4-unit cartridge
- 20 units = one 12-unit + one 8-unit cartridge
- 24 units = two 12-unit cartridges 4
Clinical Context and Limitations
- Afrezza is a prandial (mealtime) insulin only - it must be combined with basal insulin in type 1 diabetes and cannot be used for basal coverage 1, 5
- The fixed-dose increments (4,8,12 units) represent a significant limitation compared to injectable insulins that allow single-unit titration 2, 3
- Ultra-rapid pharmacokinetics: onset within 5 minutes, peak at 1-2 hours, duration 3-4 hours - faster than subcutaneous rapid-acting analogs 3, 4, 5
Important Caveats
- Single-unit increment dosing is not possible - patients requiring precise titration may face challenges with the fixed 4-unit increments 2, 3
- Contraindicated in chronic lung disease (asthma, COPD) and active smokers 1, 5
- Cost consideration: Afrezza inhalation cartridges have substantially higher cost per 1,000 units ($1,503 AWP, $1,298 NADAC) compared to injectable rapid-acting insulins 1
- Not suitable for diabetic ketoacidosis or as basal insulin replacement 5